ClinicalTrials.gov
public full text
Public Domain
Dosing Intervals of Opioid Medication for Chronic Pain
This study is to determine the feasibility of an n-of-1, randomized, double blind, placebo controlled case series to examine effects of extended release opioids when used at intervals shorter than recommended by the manufacturer by people with chronic pain.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Combined Morphine and Duloxetine on Chronic Pain#1164386
- The Effect of an Additional Bolus Application in Patients With Intrathecal Opiate Administration - a Pilot Study#848419
- Quantity of Opioids for Acute Pain and Limit Unused Medication#866948
- Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder#879870
- Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain#1170960
Record · ID 1007468
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive